aTyr Pharma Provides Regulatory and Clinical Update for Efzofitimod in Pulmonary Sarcoidosis Following FDA Type C Meeting Life Science Investing
Galectin Therapeutics Announces Publication of NAVIGATE Phase 2b Trial Results for Belapectin in the Journal of Hepatology Life Science Investing
Entera Announces First Quarter 2026 Financial Results and Updates Across its Oral Peptide Programs Life Science Investing
Traws Pharma to Advance Potential Clinical Candidates for the Treatment of Hantavirus Infections Life Science Investing
Bristol Myers Squibb Receives European Commission Approval of Sotyktu for the Treatment of Active Psoriatic Arthritis in Adults Life Science Investing
CytomX Therapeutics Announces Q1 2026 Financial Results and Provides Business Update Life Science Investing
Corvus Pharmaceuticals Provides Business Update and Reports First Quarter 2026 Financial Results Life Science Investing
